Food Allergy Clinical Research Studies

Oral Immunotherapy STUDY

Age 4-55


The main purpose of this study is to learn how well ADP101 works and how safe ADP101 is compared with placebo. ADP101 is an oral immunotherapy (OIT). OIT involves exposing somebody with food allergy (or allergies) to very small amounts of the food source(s) that causes the allergic reactions and over time slowing increasing the amount(s) (also called updosing) until a final dose is reached. The goal is to make you less sensitive to the food(s) that cause your allergic reactions. ADP101 contains 15 food sources, as follows: peanut, tree nuts (almond, cashew, hazelnut, pecan, pistachio, walnut), wheat, cow’s milk, chicken’s egg, codfish, salmon, shrimp, sesame seed, and soy.

If you’re interested in participating in a clinical research study at the Clinical Research Center of Alabama, call 205.209.4100 to speak with an experienced coordinator or fill out the contact form below.